Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 14/20 | 0.46 |
| ▸ | CDK4 | P11802 | 6/20 | 0.40 |
| ▸ | IKBKB | O14920 | 4/20 | 0.37 |
| ▸ | SYK | P43405 | 2/20 | 0.36 |
| ▸ | CDK1 | P06493 | 2/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 1/20 | 0.34 |
| ▸ | CDK9 | P50750 | 1/20 | 0.34 |
| ▸ | CCNH | P51946 | 1/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5098705 | 0.76 | CDK2 (0.53) | CDK2CDK4IKBKBCDK1 | |
| SCHEMBL4021126 | 0.73 | CDK2 (0.53) | CDK2CDK4CDK1 | |
| SCHEMBL6604661 | 0.73 | CDK2 (0.47) | CDK2CDK4IKBKBSYK | |
| SCHEMBL6600221 | 0.73 | CDK2 (0.46) | CDK2CDK4IKBKBSYK | |
| SCHEMBL6600811 | 0.72 | CDK2 (0.50) | CDK2CDK4IKBKBSYK | |
| SCHEMBL4030405 | 0.70 | CDK2 (0.63) | CDK2CDK4CDK1CCNT1CCNB1 | |
| SCHEMBL6608941 | 0.70 | CDK2 (0.44) | CDK2CDK4IKBKBSYKCDK1 | |
| SCHEMBL6606819 | 0.69 | CDK2 (0.41) | CDK2CDK4IKBKBSYKCDK1 | |
| SCHEMBL4024205 | 0.69 | CDK2 (0.56) | CDK2CDK4CDK1 | |
| SCHEMBL4020672 | 0.69 | CDK2 (0.54) | CDK2CDK4CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490354-A1 | 4-IMIDAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES WITH CDK INHIBITORY ACTIVITY | Astrazeneca AB (SE) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003076434-A1 | 4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY | ASTRAZENECA AB (SE) | 2003-09-18 | — | — | WO | disclosed |